03/26/2024 16:30 |
[Delayed] Further Update on Status of Manufacturing and Marketing Approval for SB623 Chronic Traumatic |
03/19/2024 15:00 |
Presentation for Financial Results for the Fiscal Year Ending Jan.31, 2024 |
03/18/2024 15:00 |
Consolidated Financial Results for the Fiscal Year Ended January 31, 2024 [Japanese GAAP] |
03/18/2024 15:00 |
Announcement on Reduction in Amounts of Stated Capital and Capital Reserves and Appropriation of Other Capital Surplus |
03/18/2024 15:00 |
Notice Concerning Differences between Consolidated Earnings Forecast and Actual Results for the Fiscal Year Ending January 31, 2024 |
03/18/2024 15:00 |
Notice Concerning Recording of Non-operating Income, Extraordinary Gains, and Deferred Income Taxes |
03/18/2024 14:30 |
Further Update on Status of Manufacturing and Marketing Approval for SB623 Chronic Traumatic |
02/13/2024 15:00 |
[Delayed] Progress on Disclosed Matters: Completion of Liquidation of Overseas Subsidiary |
01/25/2024 18:00 |
Further Update on Status of Manufacturing and Marketing Approval for SB623 Chronic Traumatic Brain Injury (TBI) Program in Japan |
01/09/2024 15:00 |
Announcement on Acquisition and Cancellation of Stock Options (Share Acquisition Rights) |
12/20/2023 15:00 |
[Delayed] Notice Regarding the Transfer of Non-Current Assets of Consolidated Subsidiary and Recording of Extarordinary Gain |
12/14/2023 15:00 |
Announcement of Result of Restructuring including Personnel Reduction at Overseas Subsidiary |
12/14/2023 15:00 |
Further Update on Status of Manufacturing and Marketing Approval for SB623 Chronic Traumatic Brain Injury (TBI) Program in Japan |
12/14/2023 15:00 |
Notice Concerning Recording of Non-operating Income, Extraordinary Gains, and Deferred Income Taxes |
12/14/2023 15:00 |
Consolidated Financial Results for the Nine Months Ended October 31, 2023 [Japanese GAAP] |
09/15/2023 15:00 |
Presentation for Financial Results for the 2nd Quarter of the Fiscal Year Ending January 31, 2024 |
09/14/2023 15:00 |
Notice Concerning Differences between Consolidated Earnings Forecast and Actual Results for the First Half of the Fiscal Year Ending January 31, 2024 |
09/14/2023 15:00 |
Notice Concerning Recording of Non-operating Income and Deferred Income Taxes |
09/14/2023 15:00 |
Consolidated Financial Results for the Six Months Ended July 31, 2023 [Japanese GAAP] |
08/31/2023 15:00 |
Further Update on Status of Manufacturing and Marketing Approval for SB623 Chronic Traumatic Brain Injury (TBI) Program in Japan |
07/11/2023 15:00 |
[Delayed] Restructuring including Personnel Reduction at Overseas Subsidiary |
06/14/2023 15:00 |
Further Update on Status of Manufacturing and Marketing Approval for SB623 Chronic Traumatic Brain Injury (TBI) Program in Japan |
06/14/2023 15:00 |
Consolidated Financial Results for the Three Months Ended April 30, 2023 [Japanese GAAP] |
06/14/2023 15:00 |
Notice Concerning Recording of Non-operating Income, Extraordinary Gains, and Deferred Income Taxes |